S 320 – New YorkStatus: In Process
Year Introduced: 2021
Requires investigating of critical prescription drug pricing; provides for civil penalties and private actions for certain critical prescription drug pricing. The added section empowers the superintendent to investigate any increase in a “critical prescription drug” as defined in the amendment that exceeds
the consumer list price index during any preceding twelve month period.
Return to Database Search
© 2018-2019 The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.